chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 80.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 79.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 93.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 29.0
Sex: F
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: Narrative:  J&J vaccine administered 9/12/21, dx with DVT 10/19/21
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Nausea, Pain
Clinical narrative: Narrative: Pt experienced headache, nausea, and body ache s/p COVID-19 (pfizer) booster vaccination on 3/9/2022. Per MD evaluation on3/10/2022, "Patient seen as was having nausea, feeling ill after vaccine yesterday. No reactions from prior vaccinations. Feeling much better today, participating in therapies, no dizziness, chest pain, SOB, nausea. Exam stable, at baseline." Patient ordered acetaminiphen 650mg po q4h prn headache and requested 1 dose on 3/12/2022.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Dyspnoea exertional, Productive cough, Tobacco user
Clinical narrative: Narrative: This is a 64-year-old male with a history of COPD, on 1.5 L nasal cannula of oxygen at night and as needed during the day, who presents to the emergency department with worsening shortness of breath over the last 10 days. He reports since getting his COVID-19 booster, he has felt more short of breath. He has had a lot of phlegm in his throat with productive cough, but has not noticed any wheezing or fevers. He denies runny nose or sinus congestion, denies any known allergies. He denies nausea, vomiting, diarrhea, or sick contacts. The patient does continue to smoke. He denies any chest pain, except occasionally with coughing. The patient denies any falls or trauma, no known anemia or blood in his stool. He has noted shortness of breath with exertion, but no chest pain or lower extremity edema. He denies any known heart problems, no history of thromboembolic disease. The patient does use a motorized wheelchair when he is out of the house, but has been ambulatory within his house. His shortness of breath seemed progressive, thus he presents for evaluation. The patient is immunocompromised due to Biologics (Humira) for arthritis/ankylosing spondylitis.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Wheelchair user
Clinical narrative: Narrative: This is a 64-year-old male with a history of COPD, on 1.5 L nasal cannula of oxygen at night and as needed during the day, who presents to the emergency department with worsening shortness of breath over the last 10 days. He reports since getting his COVID-19 booster, he has felt more short of breath. He has had a lot of phlegm in his throat with productive cough, but has not noticed any wheezing or fevers. He denies runny nose or sinus congestion, denies any known allergies. He denies nausea, vomiting, diarrhea, or sick contacts. The patient does continue to smoke. He denies any chest pain, except occasionally with coughing. The patient denies any falls or trauma, no known anemia or blood in his stool. He has noted shortness of breath with exertion, but no chest pain or lower extremity edema. He denies any known heart problems, no history of thromboembolic disease. The patient does use a motorized wheelchair when he is out of the house, but has been ambulatory within his house. His shortness of breath seemed progressive, thus he presents for evaluation. The patient is immunocompromised due to Biologics (Humira) for arthritis/ankylosing spondylitis.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram cerebral abnormal, Angiogram normal, Arteriosclerosis, Basal ganglia infarction, Carotid artery stenosis
Clinical narrative: Narrative:  Patient is a 65 year old MALE with PMH significant for CVD s/p TIA on 6/4/21, GERD, COPD, adjusted disorder with mixed disturbance of emotions and conduct. Pt received Janssen COVID-19 vaccine on 4/9/21. No ADEs immediately after administration per chart review. Per 6/14/21 fax of records, pt presented to ED on 6/4/21 with sudden onset of slurred speech and R sided weakness and numbness. CT head was negative and CT showed no large vessel occlusion. Tele neurology was consulted and TPA administered and admitted to ICU for post TPA monitoring. MRI was done which showed a left periventricular and left basal ganglia small infarct. Repeat CT head after 24 hours was negative. Echocardiogram with bubble was done which was negative for a shunt. Patient was seen by Neurology who recommended PT OT and ST. They also recommended aspirin and statin. Later admitted to rehab at facility x 2 weeks and since then pt has been followed by PT for rehabilitation. No hx of HTN/CAD/DM prior to TIA. Risk factors include history of tobacco usage per screening reminders but pt had quit some time prior to 8/25/20 per nursing outpatient progress note. History of substance usage in 2015 with (+) UDS with methamphetamine at clinic but reports one time usage per 5/25/16 PCP f/u. No (+) UDS per clinic draws since.  Pt currently on olanzapine up to 10 mg QHS (since 8/21/20) - previously on quetiapine up to 50 mg QHS (9/13/19-8/21/20).  Antipsychotics could increase risk of ASCVD.  On 9/21/21, at f/u with PCP, pt requested COVID vaccine booster from Pfizer or Moderna as pt felt that J&J vaccination was related to TIA on 6/14/21. None administered at the time d/t no updated guidance from the CDC on administering boosters for people who received the J&J vaccine.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral artery stenosis, Cerebral infarction, Computerised tomogram head normal, Dysarthria, Echocardiogram normal
Clinical narrative: Narrative:  Patient is a 65 year old MALE with PMH significant for CVD s/p TIA on 6/4/21, GERD, COPD, adjusted disorder with mixed disturbance of emotions and conduct. Pt received Janssen COVID-19 vaccine on 4/9/21. No ADEs immediately after administration per chart review. Per 6/14/21 fax of records, pt presented to ED on 6/4/21 with sudden onset of slurred speech and R sided weakness and numbness. CT head was negative and CT showed no large vessel occlusion. Tele neurology was consulted and TPA administered and admitted to ICU for post TPA monitoring. MRI was done which showed a left periventricular and left basal ganglia small infarct. Repeat CT head after 24 hours was negative. Echocardiogram with bubble was done which was negative for a shunt. Patient was seen by Neurology who recommended PT OT and ST. They also recommended aspirin and statin. Later admitted to rehab at facility x 2 weeks and since then pt has been followed by PT for rehabilitation. No hx of HTN/CAD/DM prior to TIA. Risk factors include history of tobacco usage per screening reminders but pt had quit some time prior to 8/25/20 per nursing outpatient progress note. History of substance usage in 2015 with (+) UDS with methamphetamine at clinic but reports one time usage per 5/25/16 PCP f/u. No (+) UDS per clinic draws since.  Pt currently on olanzapine up to 10 mg QHS (since 8/21/20) - previously on quetiapine up to 50 mg QHS (9/13/19-8/21/20).  Antipsychotics could increase risk of ASCVD.  On 9/21/21, at f/u with PCP, pt requested COVID vaccine booster from Pfizer or Moderna as pt felt that J&J vaccination was related to TIA on 6/14/21. None administered at the time d/t no updated guidance from the CDC on administering boosters for people who received the J&J vaccine.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Hemiparesis, Hypoaesthesia, Immunisation reaction, Intensive care, Magnetic resonance imaging head abnormal
Clinical narrative: Narrative:  Patient is a 65 year old MALE with PMH significant for CVD s/p TIA on 6/4/21, GERD, COPD, adjusted disorder with mixed disturbance of emotions and conduct. Pt received Janssen COVID-19 vaccine on 4/9/21. No ADEs immediately after administration per chart review. Per 6/14/21 fax of records, pt presented to ED on 6/4/21 with sudden onset of slurred speech and R sided weakness and numbness. CT head was negative and CT showed no large vessel occlusion. Tele neurology was consulted and TPA administered and admitted to ICU for post TPA monitoring. MRI was done which showed a left periventricular and left basal ganglia small infarct. Repeat CT head after 24 hours was negative. Echocardiogram with bubble was done which was negative for a shunt. Patient was seen by Neurology who recommended PT OT and ST. They also recommended aspirin and statin. Later admitted to rehab at facility x 2 weeks and since then pt has been followed by PT for rehabilitation. No hx of HTN/CAD/DM prior to TIA. Risk factors include history of tobacco usage per screening reminders but pt had quit some time prior to 8/25/20 per nursing outpatient progress note. History of substance usage in 2015 with (+) UDS with methamphetamine at clinic but reports one time usage per 5/25/16 PCP f/u. No (+) UDS per clinic draws since.  Pt currently on olanzapine up to 10 mg QHS (since 8/21/20) - previously on quetiapine up to 50 mg QHS (9/13/19-8/21/20).  Antipsychotics could increase risk of ASCVD.  On 9/21/21, at f/u with PCP, pt requested COVID vaccine booster from Pfizer or Moderna as pt felt that J&J vaccination was related to TIA on 6/14/21. None administered at the time d/t no updated guidance from the CDC on administering boosters for people who received the J&J vaccine.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Scan with contrast abnormal, Transient ischaemic attack
Clinical narrative: Narrative:  Patient is a 65 year old MALE with PMH significant for CVD s/p TIA on 6/4/21, GERD, COPD, adjusted disorder with mixed disturbance of emotions and conduct. Pt received Janssen COVID-19 vaccine on 4/9/21. No ADEs immediately after administration per chart review. Per 6/14/21 fax of records, pt presented to ED on 6/4/21 with sudden onset of slurred speech and R sided weakness and numbness. CT head was negative and CT showed no large vessel occlusion. Tele neurology was consulted and TPA administered and admitted to ICU for post TPA monitoring. MRI was done which showed a left periventricular and left basal ganglia small infarct. Repeat CT head after 24 hours was negative. Echocardiogram with bubble was done which was negative for a shunt. Patient was seen by Neurology who recommended PT OT and ST. They also recommended aspirin and statin. Later admitted to rehab at facility x 2 weeks and since then pt has been followed by PT for rehabilitation. No hx of HTN/CAD/DM prior to TIA. Risk factors include history of tobacco usage per screening reminders but pt had quit some time prior to 8/25/20 per nursing outpatient progress note. History of substance usage in 2015 with (+) UDS with methamphetamine at clinic but reports one time usage per 5/25/16 PCP f/u. No (+) UDS per clinic draws since.  Pt currently on olanzapine up to 10 mg QHS (since 8/21/20) - previously on quetiapine up to 50 mg QHS (9/13/19-8/21/20).  Antipsychotics could increase risk of ASCVD.  On 9/21/21, at f/u with PCP, pt requested COVID vaccine booster from Pfizer or Moderna as pt felt that J&J vaccination was related to TIA on 6/14/21. None administered at the time d/t no updated guidance from the CDC on administering boosters for people who received the J&J vaccine.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Narrative:  Syringe was drawn up from the vial on 6/1, 0.5 ml. It was not utilized or disposed of on 6/1 as would be appropriate for a 12 hour BUD. Since it was not disposed of per procedure and left in the vaccine prep area, the 6/2 staff did note the 6/1 date and utilized this syringe to split and make two 0.25 ml booster vaccine doses. These were administered. No adverse outcome identified.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Malaise, Palpitations
Clinical narrative: Narrative: The patient received his 4th covid vaccine and did not feel well after. Two days later he felt palpitations so went into the ED and was diagnosed with A Fib with RVR.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: Narrative: The patient received the J&J vaccine at an outside facility and 4 weeks later presented to the ED with a DVT
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dementia
Clinical narrative: Narrative:  75yo male died on 5-22-22 at skilled nursing facility. Pt had received a covid J&J vaccine on 6/9/2021. It appears death is not related to this vaccine. Pt with declined dementia.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID fully vaccinated, presents with diarrhea incidental COVID positive, admitted for observation
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Fully COVID vaccinated, admitted with shortness of breath and COVID positive
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Pain, Rash
Clinical narrative: Narrative:  Patient had his second shingles vaccine on Friday and that he then developed a rash all over his body, some pain, and blisters are forming. She reports that he also had a testosterone shot morning of the same day prior to coming to the clinic. She says that he has been doing the otc medication (benadryl) that was recommended by nurse that they spoke with on Friday.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cerebrovascular accident, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Fully vaccinated patient admitted for CVA found to be COVID positive incidentally
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Mental status changes
Clinical narrative: Narrative:  Fully vaccinated, admitted for AMS following hospital discharge for COVID-19. AMS improved during hospitalization and patient was discharged.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Localised infection, SARS-CoV-2 test positive, Skin necrosis
Clinical narrative: Narrative:  Fully vaccinated, admitted for infected/necrotic foot infection, found to be COVID positive accidently
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Localised infection, SARS-CoV-2 test positive, Skin necrosis, Wound infection
Clinical narrative: Narrative:  Fully vaccinated patient admitted for infected/necrotic foot wound found to be COVID positive incidentally
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Fully COVID vaccinated, positive on admission and passed away due to hypoxic respiratory failure due to COVID
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Intensive care, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Narrative: Patient admitted 10/19/21 to ICU (fully COVID vaccinated, doses on 1/28 and 2/1/21 Pfizer) with positive COVID test on 10/18/21. Patient admitted with sepsis, passed away on 10/19/21 due to sepsis per notes.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Respiratory failure
Clinical narrative: Narrative:  Per notes, patient was admitted to a local hospital on 5/3/22 with shortness of breath/respiratory failure and was offered intubation; however he did not want any further intervention and was made DNR/DNI. No other records from facility are available. There were 15 days from time of second booster to date of death. No autopsy report available.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest discomfort, Lethargy, SARS-CoV-2 test positive
Clinical narrative: Narrative: Fully COVID vaccinated, h/o prior COVID positive 2 weeks prior, admitted with weakness, lethargy, chest tightness and COVID positive
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: , received a "booster" dose of Moderna Vaccine at approximately 3:19 P.M. and expired at 4:48 P.M the same day. Autopsy declined. Patient also received a Bisacodyl supp
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Allergy to vaccine, Discomfort, Dry skin, Erythema, Hypersensitivity
Clinical narrative: Narrative:  04/14/22 Per nursing primary care note, pt received first dose of Shingrix vaccine 04/16/22 Per ambulatory secure messaging, pt reports a worsening rash that started to show up on 04/15 04/17/22 Per ambulatory secure messaging, pt reports rash is not getting better but has been using hydrocortisone cream which helped with minor discomfort 04/18/22 Per ambulatory secure messaging, pt sent an image of the rash and provider responded stating that it appears the pt is having an allergic reaction to the vaccine; recommended to take OTC Benadryl and if the rash does not resolve to seek evaluation at an ER 04/20/22 Per ambulatory secure messaging, pt reports most of his arm is red and itchy but not "too itchy" 04/21/22 Per ambulatory secure messaging, pt confirms he is still taking OTC Benadryl 04/22/22 Per ambulatory secure messaging, pt reports little red blotches on leg with mild itching but does not hurt 04/25/22 Per interim ambulatory care note, rash is resolving and flaky dry skin remains over arms; no sx of swelling, SOB, or respiratory distress
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus, Rash, Rash macular, Skin exfoliation
Clinical narrative: Narrative:  04/14/22 Per nursing primary care note, pt received first dose of Shingrix vaccine 04/16/22 Per ambulatory secure messaging, pt reports a worsening rash that started to show up on 04/15 04/17/22 Per ambulatory secure messaging, pt reports rash is not getting better but has been using hydrocortisone cream which helped with minor discomfort 04/18/22 Per ambulatory secure messaging, pt sent an image of the rash and provider responded stating that it appears the pt is having an allergic reaction to the vaccine; recommended to take OTC Benadryl and if the rash does not resolve to seek evaluation at an ER 04/20/22 Per ambulatory secure messaging, pt reports most of his arm is red and itchy but not "too itchy" 04/21/22 Per ambulatory secure messaging, pt confirms he is still taking OTC Benadryl 04/22/22 Per ambulatory secure messaging, pt reports little red blotches on leg with mild itching but does not hurt 04/25/22 Per interim ambulatory care note, rash is resolving and flaky dry skin remains over arms; no sx of swelling, SOB, or respiratory distress
Age: 65.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Endotracheal intubation, Hypoglycaemia, Oxygen saturation decreased
Clinical narrative: Narrative: Patient COVID positive on 8/9/21 (fully vaccinated) admitted for hypoglycemia and tachycardia. Patient began requiring HFNC with suboptimal saturations and ultimately required intubation on 8/13/21. Patient then developed septic shock and passed away on 8/18/21.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Tachycardia
Clinical narrative: Narrative: Patient COVID positive on 8/9/21 (fully vaccinated) admitted for hypoglycemia and tachycardia. Patient began requiring HFNC with suboptimal saturations and ultimately required intubation on 8/13/21. Patient then developed septic shock and passed away on 8/18/21.
Age: 75.0
Sex: M
Vaccine: PPV
Symptoms: Rash
Clinical narrative: Narrative:  Pt received the PPSV23 vaccine and then called back to let staff know he had a rash "head to toe." He was prescribed a medrol dose pack, and no complaints were noted after medication mailed.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, COVID-19, COVID-19 pneumonia, Cardiac arrest, Death
Clinical narrative: Narrative:  Patient COVID positive on 7/12/21 (fully vaccinated) and admitted with hypoxic respiratory failure secondary to COVID pneumonia. Patient was transferred to ICU on 7/15 and intubated on 7/21. Patient passed away on 7/26/21 following PEA arrest d/t COVID ARDs.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Intensive care, Pulseless electrical activity, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient COVID positive on 7/12/21 (fully vaccinated) and admitted with hypoxic respiratory failure secondary to COVID pneumonia. Patient was transferred to ICU on 7/15 and intubated on 7/21. Patient passed away on 7/26/21 following PEA arrest d/t COVID ARDs.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cough, Respiratory tract congestion
Clinical narrative: Narrative:  Patient with h/o COVID-19 positive test on 8/2 at outside facility admitted to hospital on 8/8/21 with COVID-19 pneumonia, acute hypoxic respiratory failure, cough, and congestion. Patient completed treatment inpatient and was discharged from facility. Patient completed COVID-19 Pfizer vaccines on 3/3/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient with h/o COVID-19 positive test on 8/2 at outside facility admitted to hospital on 8/8/21 with COVID-19 pneumonia, acute hypoxic respiratory failure, cough, and congestion. Patient completed treatment inpatient and was discharged from facility. Patient completed COVID-19 Pfizer vaccines on 3/3/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Hospitalization, COVID positive and fully vaccinated upon admission, admitted for weakness that occurred for 3 days
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure, Hypervolaemia, SARS-CoV-2 test positive
Clinical narrative: Narrative: Hospitalization: COVID-19 fully vaccinated, COVID-19 positive upon admission for fluid overload due to acute HF exacerbation
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fall, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Hospitalization: COVID-19 fully vaccinated, found to be COVID-19 positive upon admission after presenting to ER after a fall and reported AMS
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure acute, Oedema, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Hospitalization: COVID-19 fully vaccinated, COVID-19 positive upon admission for edema due to suspected acute decompensated HF
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Decreased appetite, Pain, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Hospitalization, COVID positive and fully vaccinated upon admission, admitted for body aches, decreased appetite, and weakness
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dysarthria, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Hospitalization: COVID-19 fully vaccinated, incidentally found to be COVID-19 positive after test obtained for discharge 3 days after admission for slurred speech and possible TIA
Sex: F
Vaccine: PNC20
Symptoms: Dizziness, Erythema, Hypersomnia, Impaired work ability, Injection site pain
Clinical narrative: I had the Prevnar 20 injection. I was fine until late afternoon except for pain at I jection site. I became very lethargic so I went to bed. My husband had to check my pulse when he came to bed, because there was no response. I could not get up for work the next morning, I slept until noon. My arm was swollen, red, and very painful to touch. It itched, but could not scratch because it was painful to the touch. It is five days later and my arm is still tender and I'm now having dizziness and nausea and just want to sleep. I will take notes of new or existing symptoms.
Sex: F
Vaccine: PNC20
Symptoms: Lethargy, Mobility decreased, Nausea, Peripheral swelling, Pruritus
Clinical narrative: I had the Prevnar 20 injection. I was fine until late afternoon except for pain at I jection site. I became very lethargic so I went to bed. My husband had to check my pulse when he came to bed, because there was no response. I could not get up for work the next morning, I slept until noon. My arm was swollen, red, and very painful to touch. It itched, but could not scratch because it was painful to the touch. It is five days later and my arm is still tender and I'm now having dizziness and nausea and just want to sleep. I will take notes of new or existing symptoms.
Sex: F
Vaccine: PNC20
Symptoms: Somnolence, Tenderness
Clinical narrative: I had the Prevnar 20 injection. I was fine until late afternoon except for pain at I jection site. I became very lethargic so I went to bed. My husband had to check my pulse when he came to bed, because there was no response. I could not get up for work the next morning, I slept until noon. My arm was swollen, red, and very painful to touch. It itched, but could not scratch because it was painful to the touch. It is five days later and my arm is still tender and I'm now having dizziness and nausea and just want to sleep. I will take notes of new or existing symptoms.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Interchange of vaccine products
Clinical narrative: Narrative:  70 year old patient with PMH of small bowel obstruction, renal cyst, mass of urinary bladder, tinnitus, actinic keratosis, bilateral age related nuclear cataracts, congenital anisocoria, HTN, COPD, hx of hematuria, hypothyroidism and compression fracture (2016) received Pfizer vaccine (30mcg/0.3mL) as a booster dose on 5/17/2022. On 5/18/2022, when a dietitian called patient for a follow (unrelated to vaccine), the dietitian was notified by the family that patient passed away on 5/18/2022. According to progress notes, patient tolerated the fourth dose with no issues. Patient received Moderna x3 for the previous 3 doses. Reporting this event even though we are unsure of the correlation since patient passed away the next day post-vaccine. No other progress notes found regarding the situation in CPRS. PCP has been notified.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Agitation, Angiogram pulmonary abnormal, Anxiety, Blood creatinine normal
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood gases abnormal, Blood lactic acid, Blood urea normal, C-reactive protein increased, COVID-19
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Condition aggravated, Convalescent plasma transfusion, Death
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Endotracheal intubation, Fatigue, Fibrin D dimer increased, Haemoglobin decreased
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Hypoxia, Intensive care, Lung infiltration, Lung opacity
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mechanical ventilation, Mechanical ventilation complication, Myalgia, Platelet count decreased, Procalcitonin
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Productive cough, Pyrexia, Red blood cell sedimentation rate increased, Respiratory alkalosis, SARS-CoV-2 test positive
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Serratia bacteraemia, Stress ulcer, Tachycardia, Vaccination failure, White blood cell count normal
Clinical narrative: Narrative: Vaccine failure as pt died 2/2 COVID-19 pna
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac fibrillation, Cerebrovascular accident, Computerised tomogram head abnormal, Pyrexia, Thrombosis
Clinical narrative: Switch from pfister to medor COVID vaccine. In my mid 60's have art. fib. Fever for 2 days. Developed blood clot and had a stroke
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Narrative: Admitted to hospital with complications caused by a "breakthrough" COVID infection.
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, Chest X-ray abnormal, Chest discomfort, Electrocardiogram abnormal, Erythema
Clinical narrative: Patient is communicated to notify that on May 21, 2022 the Covid 19 booster vaccine (modern) was given and on May 31 the dose of Repatha was put on. A week later on June 8, 2022 he began to present a skin reaction of itching, redness and burning. She went to the emergency room and was treated with Benadryl by later discharge.On Friday, June 10, 2022, I return to the emergency room with chest pressure and the same skin symptoms. She had EKG, chest x-ray and blood tests, but the results were all negative. She was treated with Benadryl and discharged.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin burning sensation
Clinical narrative: Patient is communicated to notify that on May 21, 2022 the Covid 19 booster vaccine (modern) was given and on May 31 the dose of Repatha was put on. A week later on June 8, 2022 he began to present a skin reaction of itching, redness and burning. She went to the emergency room and was treated with Benadryl by later discharge.On Friday, June 10, 2022, I return to the emergency room with chest pressure and the same skin symptoms. She had EKG, chest x-ray and blood tests, but the results were all negative. She was treated with Benadryl and discharged.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Dyspnoea, Peripheral swelling
Clinical narrative: Narrative:  Pt received J&J COVID vaccine on 9/7/21 and within approx 42 days (on 10/21/21) presented to local ER with SOB and swelling of leg, dx with right leg DVT and PE. This was first incidence of PE or DVT. Past h/o iliac artery stent in 2016.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Pneumonia, Respiratory failure
Clinical narrative: Narrative:  Admission: fully vaccinated, COVID positive admitted with CAP/COVID pneumonia, passed away during admission. Patient passed away 1/13/22 due to hypoxic respiratory failure reported as secondary to COVID pneumonia.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  Admission: fully vaccinated, COVID positive admitted with CAP/COVID pneumonia, passed away during admission. Patient passed away 1/13/22 due to hypoxic respiratory failure reported as secondary to COVID pneumonia.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Leg amputation, Malaise, Osteomyelitis
Clinical narrative: Narrative:  Vaccinated pt who developed symptomatic COVID while admitted for osteomyelitis requiring BKA. Ultimately discharged to SNF
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Seborrhoea
Clinical narrative: NOTICED 1 WK AFTER SHOT 2 SOME GREASY SWEAT ABOUT EARS. IT KEPT GETTING WORSE SO ASKED NURSE ABOUT IT. SHE REPLIED SOME OTHER CASES HAD STOPPED AND HAD NOTHING TO GIVE ME. 4-21 AT DERMATOGIST-GIVEN RX FOR CLOBETASAL .05 % SHAMPOO, CLOBETASAL SOLUTION, RETOCONAZALE 2% SHAMPOO.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise
Clinical narrative: Narrative:  Vaccinated, not boosted pt admitted for symptomatic COVID, discharged after 2 day admission.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Intensive care, Pneumonia bacterial
Clinical narrative: Narrative:  Vaccinated, not boosted patient admitted for COVID and bacterial PNA. Required ICU care and transitioned to palliative care. Ultimately Deceased
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Admission: Fully vaccinated, COVID positive admitted for COVID pneumonia
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Admission: fully vaccinated, COVID positive admitted with COVID pneumonia
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Mental disorder, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Hospitalization: Fully COVID vaccinated, admitted 5/11/22 for geri-psych placement incidentally COVID positive on 5/21/22
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Small intestinal obstruction
Clinical narrative: Narrative:  Hospitalization, COVID positive and fully vaccinated upon admission, admitted for small bowel obstruction
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Hemiplegia, Imaging procedure, Multiple sclerosis relapse, Neurological examination
Clinical narrative: Narrative: Severe vomiting and R sided hemiplegia requiring hosoitalization and full neurologic evaluation with imaging. Discharge diagnosis was pseudoexacerbation of underlying autoimmune disorder Multiple Sclerosis. Future vaccinations to be avoided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Narrative: Severe vomiting and R sided hemiplegia requiring hosoitalization and full neurologic evaluation with imaging. Discharge diagnosis was pseudoexacerbation of underlying autoimmune disorder Multiple Sclerosis. Future vaccinations to be avoided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pollakiuria, Productive cough, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Hospitalization, COVID positive and fully vaccinated upon admission, admitted for productive cough and urinary frequency
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Hospitalization, COVID positive and fully vaccinated upon admission, admitted for cough
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Malaise, Oropharyngeal pain
Clinical narrative: Patient is fully vaccinated. COVID positive on 5/13/2022 at ED visit.  44-year-old female who presents complaining of cough, congestion, sore throat and fatigue.  Patient states that she has been sick for approximately 1 day.  Denies any nausea or vomiting.  Denies any chest pain, leg pain, leg swelling, shortness of breath.  Unknown if any sick contacts. no fever. VSS. SpO2 100%Patient was given Decadron, Toradol, and viscous lidocaine with some relief.She was given prescription for Motrin and Zofran for home.  Quarantine instructions given.  Discharged home.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated. COVID positive on 5/13/2022 at ED visit.  44-year-old female who presents complaining of cough, congestion, sore throat and fatigue.  Patient states that she has been sick for approximately 1 day.  Denies any nausea or vomiting.  Denies any chest pain, leg pain, leg swelling, shortness of breath.  Unknown if any sick contacts. no fever. VSS. SpO2 100%Patient was given Decadron, Toradol, and viscous lidocaine with some relief.She was given prescription for Motrin and Zofran for home.  Quarantine instructions given.  Discharged home.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Oropharyngeal pain, Pruritus, Pyrexia
Clinical narrative: Intense itching of feet and hands approximately 33 hours after dosing.  Also experienced fever, chills and a sore throat after approximately 4 hours of dosing.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Pfizer 4/7/21, 4/10/21, 4/23/21. Positive on 6/13/22
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Interchange of vaccine products, SARS-CoV-2 test positive
Clinical narrative: Janssen 3/24/21. Moderna 1/5/22. Positive on 6/6/22
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed breakthrough case  COVID-19 (Moderna) 1 01/14/2021 Moderna 026L20A   COVID-19 (Moderna) 2 02/09/2021 Moderna 007M20A   COVID-19 (Moderna) 3 10/29/2021 Moderna 076C21A
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal discomfort, Oropharyngeal discomfort
Clinical narrative: Approximately 15 minutes after receiving injection, patient reported her nose and throat "felt funny".  Patient was directed to Emergency Department of parent facility.  Patient was examined by ED physician.  Symptoms did not progress.  No treatment was provided.  Patient was discharged home after 1 hour.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough   COVID-19 (Moderna) 1 04/29/2021 Hospital Moderna 007B21A   COVID-19 (Moderna) 2 05/26/2021 Hospital Moderna 043B21A
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed breakthrough Case  COVID-19 (Moderna) 1 08/09/2021 Moderna 043B21A   COVID-19 (Moderna) 2 09/02/2021  Moderna  043B21A
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Extra dose administered, SARS-CoV-2 test positive
Clinical narrative: Pt. Deceased - Cant confirm in system.   Johnson and Johnson Dose 3/31/2021  042a21a
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Possible temperature excursion.  No adverse events for patient.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: possible temperature excursion.  no adverse reaction to patient
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough Case  COVID-19 (Moderna) 1 02/03/2021 Moderna 038K20A   COVID-19 (Moderna) 2 03/03/2021 Moderna 012A21A   COVID-19 (Moderna) 3 10/29/2021 Moderna 939905
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Confirmed Breakthrough Case  COVID-19 (Pfizer) 1  09/28/2021  Pharmacy Pfizer 30135BA   COVID-19 (Pfizer) 2 10/26/2021 Pharmacy  Pfizer FF2593
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient developed COVID-19 after vaccinations had been given.
Age: 91.0
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, International normalised ratio increased, Laboratory test
Clinical narrative: Patient got his Shingrix vaccination at Pharmacy on June 6, 2022.  He reported to his wife on June 7th, that he felt very fatigued .  1 week later, he had his INR checked at our Cardiology office and his results were > 8.0.  This result was obtained on June 13, 2022.  For reference, his INR 3 day prior to receiving the Shingrix vaccine was 1.8 (tested on June 3, 2022).   He reported no bleeding or bruising symptoms.  There  were no changes in his diet, OTC meds, Rx meds, no other potential causes for greatly elevated INR.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: booster vaccine given too soon. last vaccine of series given 3/18/22. Mother advised by Director to recieve fourth vaccine in three months. Patient remained in office over thrirty minutes, no adverse reaction noted.
Age: 18.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Extra dose administered, No adverse event, Wrong product administered
Clinical narrative: Men B dose  #1   was ordered in  chart by  physician.  Nurse inadvertently gave Menactra instead.  When she realized the error she then gave patient the Men B that was originally ordered.  Nurse informed  charge  nurse and physician of  error.  Physician informed  patient and parent that an extra dose of Menactra was inadvertently given.  Patient was observed in clinic and no adverse effectes were reported.  Paitent and parent instructed if any  symptoms oor  side effects develop to seek immediate medical attention.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endometrial ablation, Haemorrhage, Heavy menstrual bleeding
Clinical narrative: Sudden onset menorrhagia. Had a uterine ablation to lessen the bleeding in March 2022, but periods are still heavy.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dysphagia, SARS-CoV-2 test positive
Clinical narrative: 5/27 This is a 49y.o. male here for dysphagia and point toward throat - he was agreeable to try a quick EGD to rule out esophageal etiology. There are no active hospital problems to display for this patient.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Atrial fibrillation, COVID-19, Cardiac arrest, Cardiomegaly
Clinical narrative: 12/28/21 pt to ED with generalized malaise and poor po intake; FTT x 3-4 months; found to be positive for COVID; no respiratory sx; elevated tropins; NSTEMI; no intervention recommended; pt does not want a feeding tube; supplemental shakes; pt had an episode of A Fib; 2 L O2 via NC; small pleural effusion and enlarged heart; pt went into V Fib arrest and passed away in the hospital
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Failure to thrive, Hypophagia, Malaise, Pleural effusion
Clinical narrative: 12/28/21 pt to ED with generalized malaise and poor po intake; FTT x 3-4 months; found to be positive for COVID; no respiratory sx; elevated tropins; NSTEMI; no intervention recommended; pt does not want a feeding tube; supplemental shakes; pt had an episode of A Fib; 2 L O2 via NC; small pleural effusion and enlarged heart; pt went into V Fib arrest and passed away in the hospital
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin increased, Ventricular fibrillation
Clinical narrative: 12/28/21 pt to ED with generalized malaise and poor po intake; FTT x 3-4 months; found to be positive for COVID; no respiratory sx; elevated tropins; NSTEMI; no intervention recommended; pt does not want a feeding tube; supplemental shakes; pt had an episode of A Fib; 2 L O2 via NC; small pleural effusion and enlarged heart; pt went into V Fib arrest and passed away in the hospital
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Flank pain, SARS-CoV-2 test positive
Clinical narrative: 6/4 71y.o. male with PMH CAD s/p CABG, PAD s/p BLE stents, COPD presenting for R flank pain. Pt's symptoms developed 2 days ago when he had R flank pain.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Delivery, Maternal exposure before pregnancy, SARS-CoV-2 test positive, Uterine contractions during pregnancy
Clinical narrative: 6/7 35y.o. G3P2002 at 39w0d by s presents to Triage with c/o contractions. 6/7 SVD of baby girl
Age: 96.0
Sex: U
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Pt diagnosed with Covid.  Pt had Covid vaccine
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, COVID-19, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative:  Hospitalization: COVID-19 fully vaccinated, found to be COVID-19 positive upon admission after presenting to the ER with N/V found to have significant high-risk NSTEMI
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Expired product administered
Clinical narrative: Patient was needing to get caught up on his vaccine, So when I was getting those ready I realized it was a brand new box didn't think of checking the dates since it was a new box plus it was a pretty busy morning for me so I was rushing so I wouldn't get behind.  when I went to the room I gave the vaccine and when I was goin to chart it I realized it was an expired date and that patient and mother had already left. so I let my Supervisor know what had happened and I gave her the box of vaccines. had called the parent and let them know what happened let them know that he would need to come in an get a booster kinrex.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case. Moderna 030A21A 3/12/21, 018B21A 4/9/21 and boosted 042J21A 2/21/22.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, COVID-19, Cardiac arrest, Condition aggravated, Cough
Clinical narrative: PFIZER COVID VACCINE #3 GIVEN 9/8/21, LOT #FF2589; 1/13/22 pt to ED with increasing SOB and cough; states had a positive COVID test 2 days prior to coming to ED; sx have worsened; positive COVID test in ED; pt diaphoretic and c/o epigastric pain without radiation; found to have moderate to large pericardial effusion; during hospitalization, pt experienced cardiac arrest - repeat episodes; intubated; transferred to MICU; given IV ABX and IV pressors; family then made pt a DNR, comfort care; pt extubated and he passed away in the hospital
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Endotracheal intubation, Hyperhidrosis, Intensive care
Clinical narrative: PFIZER COVID VACCINE #3 GIVEN 9/8/21, LOT #FF2589; 1/13/22 pt to ED with increasing SOB and cough; states had a positive COVID test 2 days prior to coming to ED; sx have worsened; positive COVID test in ED; pt diaphoretic and c/o epigastric pain without radiation; found to have moderate to large pericardial effusion; during hospitalization, pt experienced cardiac arrest - repeat episodes; intubated; transferred to MICU; given IV ABX and IV pressors; family then made pt a DNR, comfort care; pt extubated and he passed away in the hospital
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pericardial effusion, SARS-CoV-2 test positive
Clinical narrative: PFIZER COVID VACCINE #3 GIVEN 9/8/21, LOT #FF2589; 1/13/22 pt to ED with increasing SOB and cough; states had a positive COVID test 2 days prior to coming to ED; sx have worsened; positive COVID test in ED; pt diaphoretic and c/o epigastric pain without radiation; found to have moderate to large pericardial effusion; during hospitalization, pt experienced cardiac arrest - repeat episodes; intubated; transferred to MICU; given IV ABX and IV pressors; family then made pt a DNR, comfort care; pt extubated and he passed away in the hospital
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy bone marrow, Blood magnesium decreased, Body temperature increased, COVID-19, Confusional state
Clinical narrative: Pt to ED 4/18 for GI bleeding and altered mental status, pt awake and continues to be confused, pt is A&O x 1. 4/20 pt without new complaints; feeling better; no chest pain/palpitations, stable. 4/27 Sepsis BPA firing, but pt remains A&Ox3-4 and showing no s/s of distress. 5/1 Pt Magnesium still low, replacement done with Mg Sulfate 1gm IV x 3 doses per electrolyte replacement. 5/2 No acute complaints, denied being in pain. 5/4 pt A&Ox3 with some forgetfulness, VSS on room air, with no change in the pt assessment, pt s/p bone marrow biopsy.  5/8 pt Sepsis BPA fired for a score of 9. Due to temp of 100.3, HR 113, and WBC being 18.5. Pt tolerated procedure well. 5/13 Pt c/o cold symptoms, COVID+, discharged 5/13.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrolyte substitution therapy, Gastrointestinal haemorrhage, Memory impairment, Mental status changes, Nasopharyngitis
Clinical narrative: Pt to ED 4/18 for GI bleeding and altered mental status, pt awake and continues to be confused, pt is A&O x 1. 4/20 pt without new complaints; feeling better; no chest pain/palpitations, stable. 4/27 Sepsis BPA firing, but pt remains A&Ox3-4 and showing no s/s of distress. 5/1 Pt Magnesium still low, replacement done with Mg Sulfate 1gm IV x 3 doses per electrolyte replacement. 5/2 No acute complaints, denied being in pain. 5/4 pt A&Ox3 with some forgetfulness, VSS on room air, with no change in the pt assessment, pt s/p bone marrow biopsy.  5/8 pt Sepsis BPA fired for a score of 9. Due to temp of 100.3, HR 113, and WBC being 18.5. Pt tolerated procedure well. 5/13 Pt c/o cold symptoms, COVID+, discharged 5/13.